Respiratory syncytial virus (RSV) is a negative-stranded, RNA-based respiratory paramyxovirus with ten genes encoding 11 proteins. Three proteins are present in the viral envelope, including the ...

A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

The highly contagious respiratory syncytial virus (RSV) typically causes mild illness, but it can lead to severe respiratory complications, particularly for at-risk individuals. Drawing on local ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...

What if infections of respiratory syncytial virus, known as R.S.V., peak at unusual levels, as they did in the 2022-23 season? What if the new strain of mpox, which is especially virulent ...

In addition to the virus that causes COVID-19, there are many other types of respiratory viruses, including flu and respiratory syncytial virus (RSV). The good news is there are actions you can take ...

RSV, or respiratory syncytial virus ... breakthroughs made in the United States to understand the structure of the RSV virus’s fusion protein used to invade cells, the equivalent of the ...

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...